Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-051923
Filing Date
2024-12-18
Accepted
2024-12-18 18:15:13
Documents
1
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1734563707.html 4  
1 FORM 4 wk-form4_1734563707.xml 4 4202
  Complete submission text file 0001628280-24-051923.txt   5969
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Vakiener Victoria (Reporting) CIK: 0001826263 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 241560526